Abstract
BackgroundAbatacept is a novel biological T-cell modulation drug used in RA. Data on patient characteristics, diagnosis, preceding treatment and outcomes of abatacept had been collected since approval in the national...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
